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China.
METHODS We selected non-valvular atrial ﬁbrillation patients with
the age 18; CHADS2 score 1; not suitable for long-term use of
warfarin; warfarin anticoagulant drug allergies and long-term use of
poor compliance, and oral administration of aspirin and clopidogrel
may be at least 3 months after procedure. Transcatheter implantation
of LAmbre systems in LAA to prevent thromboembolism.
RESULTS The cohort included 21 consecutive patients who under-
went LAA closure with the LAmbre system. The mean age of the
patients enrolled was 66.9  8.7 years. These patients accumulated
6.7 person-years of follow-up, and with an average follow-up of
6.02.9 months. The mean CHADS2 score was 2.41.0, CHA2DS2-VASc
score was 3.61.3, and HAS-BLED score was 2.00.6. Acute procedural
success and discharged success were achieved in 100% of patients.
Mean procedure duration was 59.314.6minutes, however, there were
2 cases in patients with replacement of LAA occluder. Trans-
esophageal echocardiography demonstrated LAA leakage in 4 pa-
tients. Early pericardial effusion was noted 6 patients (28.6%) and late
pericardial effusion was diagnosed in 2 patients (9.5%). The 8 patients
who had early or late pericardial effusion were not found obvious
clinical symptoms and were treated with conservative therapy and did
not require percutaneous drainage. One patient had a right cerebellar
hemisphere infarction.
CONCLUSIONS This single-center experience revealed that LAA
closure with LAmbre system to prevent thrombosis in patients with
AF in China is safety and feasibility.
GW26-e4428
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OBJECTIVES To investigate the risk factors of atrial ﬁbrillation (AF) in
Xinjiang Xinjiang Uygurs and Hans patients, and compare differences
in clinical characteristics and associated risk factors between Uygurs
and Hans patients.
METHODS 207 cases were collected, which involved Hans and Uygurs
patients in First afﬁliated hospital of Xinjiang Medical University from
January 2010 to January 2014, among them, there were 50 Uygurs
patients and 50 Hans patients, and 49 Uygurs patients and 58 Hans
patients as control group. Collect four groups of patients with clinical
characteristics. The Age, sex, blood pressure, heart rate, left atrial
diameter (LAD), body mass index (BMI), and blood lipids were
compared in 4 groups.
RESULTS 1. Compared 2 groups of Uygurs, AF group showed
increased in age [(59.0613.342) years old vs. (52.1210.827) years old,
P ¼0.06], left atrium diameter [(36.935.74)mm, vs. (32.204.64) mm,
P ¼0.007], uric acid [(347.68130.510) umol/L, vs.(292.62102.630)
umol/L, P ¼0.022], Total cholesterol [(3.94440.89310) mmol/L, vs.
(3.40560.83607) mmol/L, P ¼0.003] and low-density lipoprotein
(LDL) [(2.74100.68985) mmol/L, vs. (2.46190.62799) mmol/L,
P ¼0.039] compared with control group, and multiple logistic
regression analysis presented that age, LAD, uric acid, Total choles-
terol were the independent risk factors for AF occurrence.
2. Compared 2 groups of Hans, AF group showed increased in age
[(65.1812.472) years old, vs. (55.4012.722) years old, P ¼0.000], left
atrium diameter [(35.885.74) mm, vs. (31.204.53) mm, P ¼0.012],
uric acid [(389.22103.132) umol/L, vs.(310.3774.085) umol/L,
P ¼0.000], Total cholesterol [(4.22321.03578) mmol/L, vs.
(3.76781.06038) mmol/L, P ¼0.027], LDL [(3.1300.8619) mmol/L,
vs. (2.4460.8739) mmol/L, P ¼0.000] compared with control group
in Hans, and multiple logistic regression analysis presented that age,
LAD, uric acid, LDL were the independent risk factors for AF occur-
rence, and the albumin may be the Protective factor for AF
occurrence.
3. The contrast of the risk factors of AF group in Uygurs and Hans,
The age of incidence of AF patients in Uygurs was yonger than in
Hans, between which the difference was signiﬁcant(P <0. 05), and the
LDL was higher in Uygurs than in Hans, there are no signiﬁcant dif-
ferences in 2 groups in uric acid, Total cholesterol, albumin(P >0.05).
CONCLUSIONS In both of AF group in Uygurs and Hans, the age, LAD,
uric acid, Total cholesterol were the risk facters for the AF occurrence,
and there were signiﬁcant differences in 2 nationalities in the clinical
feature of age and LDL.GW26-e4736
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OBJECTIVES Catheter ablation is important for treatment of atrial
ﬁbrillation (AF). Recently, a novel radiofrequency ablation catheter
using contact force sensing is claimed to be potentially responsible for
AF. However, the efﬁcacy of the contact force sensing catheter re-
mains controversial. This meta-analysis aimed to assess the efﬁcacy
and safety of the contact force (CF) sensing catheter in the treatment
of paroxysmal AF.
METHODS The randomized controlled trials (RCTs) or controlled
clinical trials (CCTs) comparing ablation for paroxysmal atrial ﬁbril-
lation using CF sensing catheter or standard non-force sensing cath-
eter were identiﬁed from PubMed, EMBASE, the Cochrane library,
Wanfang Data, and CNKI(January 1, 1998–March 1, 2015). The quality
of included RCTs or CCTs was assessed, and the meta-analysis was
conducted with RevMan 5.3 software.
RESULTS A total of six studies involving 265 patients in CF group and
465 patients in non CF group were included. The primary efﬁcacy
endpoint was AF recurrence within 12 months, which was signiﬁcantly
improved by the use of CF sensing catheter, compared with standard
non-force sensing catheter(RR ¼ 0.49, 95% CI 0.32–0.76, P < 0.01).
Also, the acute pulmonary veins (PV) reconnection was improved by
the use of CF sensing catheter, compared with standard non-force
sensing catheter(RR ¼ 0.43, 95% CI 0.18–1.05, P ¼ 0.06), but there was
no markedly differential in statistics. The incidence of complications,
including the rate of pericardial effusion(RR ¼ 0.88, 95% CI 0.27–2.90,
P ¼ 0.83), groin hematomas(RR ¼ 0.85, 95% CI 0.19–3.84, P ¼ 0.83),
and arterio-venous ﬁstula(RR ¼ 0.63, 95% CI 0.08–4.92, P ¼ 0.66) were
no statistically signiﬁcant difference between the use of CF sensing
catheter and standard non-force sensing catheter. Compared with
standard non-force sensing catheter group, ablation time(SMD¼-0.66,
95% CI -0.89– -0.43, P < 0.01), procedure duration(SMD¼-0.81, 95% CI
-1.05– -0.56, P < 0.01), ﬂuoroscopy duration(SMD¼-0.49, 95% CI -0.72–
-0.27, P < 0.01) and radiation dose(SMD¼-0.38, 95% CI -0.65– -0.11,
P < 0.01) of CF sensing catheter group were signiﬁcantly shortened.
CONCLUSIONS This systematic review and meta-analysis indicates
that ablation for paroxysmal AF with the use of CF sensing catheter
produces a better outcome compared to using standard non-force
sensing catheter during the 12-month follow-up period. The major
ﬁndings are of a signiﬁcantly higher ﬁrst time procedural success rate
with CF sensing catheter following paroxysmal AF ablation, and a
signiﬁcant reduction in ablation time, procedure duration, ﬂuoros-
copy duration and radiation dose with CF sensing catheter in all
procedures. Furthermore, the incidence of complications with the use
of CF sensing catheter was not higher than using standard non-force
sensing catheter.
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OBJECTIVES The aim of this study is to assess the long-term efﬁcacy
of enhanced ablation in PVA guided by remote magnetic navigation
(RMN) in patients with AF.
METHODS Forty consecutive patients with refractory non-valvular AF
were randomized into a conventional ablation group (CAG, n¼20) or
an enhanced ablation group (EAG, n¼20). PVA isolation was achieved
by creating a single ablation circle at the PVA in the CAG and closely
created double ablation circles at PVA in the EAG. Left and right sided
PVs were isolated as one unit respectively. An irrigated magnetic
ablation catheter, CARTO 3 mapping system and Niobe magnetic
navigation were used in both groups. A Lasso mapping catheter was
used to conﬁrm PVA isolation. Regular Holter monitoring were used to
follow up all patients.
RESULTS Forty patients had 100% PVA isolation without complica-
tions from treatment with a single procedure. Ablation energy de-
livery time in the CAG was longer than in EAG (725.261.7 vs.
568.350.6 seconds, P<0.05). There were no signiﬁcant differences in
